Journal of Immunology Research / 2022 / Article / Tab 1 / Research Article
The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with Ligilactobacillus salivarius LS01 (DSM 22775) and Bifidobacterium breve B632 (DSM 24706) Table 1 Baseline characteristics.
Total Placebo Active treatment Age Sex Female 182 (43.1%) 91 (43.3%) 91 (42.9%) Male 240 (56.9%) 119 (56.7%) 121 (57.1%) Living City 291 (69.0%) 143 (68.1%) 148 (69.8%) Rural 131 (31%) 67 (31.9%) 64 (30.2%) Passive smoking at home No 246 (58.3%) 125 (59.5%) 121 (57.1%) Father 76 (18.0%) 39 (18.6%) 37 (17.5%) Mother 32 (7.6%) 15 (7.1%) 17 (8.0%) Both 57 (13.5%) 26 (12.4%) 31 (14.6%) Other 11 (2.6%) 5 (2.4%) 6 (2.8%) School attendance No 50 (11.8%) 24 (11.4%) 26 (12.3%) Yes 372 (88.2%) 186 (88.6%) 186 (87.7%) Family atopy Yes 320 (75.8%) 168 (80.0%) 152 (71.7%) No 75 (17.8%) 30 (14.3%) 45 (21.2%) Sensitized children Yes 210 (49.8%) 104 (49.5%) 106 (50%) No 212 (50.2%) 106 (50.5%) 106 (50%)